nach oben

Erschienen in:

11.03.2021 | Review Article

Treatment of urinary incontinence: a critical appraisal of clinical practice guidelines with the AGREE II instrument

verfasst von: Flávia Blaseck Sorrilha, Lauren Giustti Mazzei, Luciane Cruz Lopes, Silvio Barberato-Filho, Juliana Castro, Analaura Castro, Claudia Marcela Vélez, Cristiane de Cássia Bergamaschi

Erschienen in: International Urogynecology Journal | Ausgabe 10/2021

Einloggen, um Zugang zu erhalten

Abstract

Introduction and hypothesis

This systematic review evaluated the rigor of the development of clinical practice guidelines (CPG).

Methods

The searched sources were MEDLINE, EMBASE, Web of Science, Scopus, and specific databases of CPG. Reviewers, organized in triplicate and independently, selected the studies and assessed the quality of the guidelines using the Appraisal of Guidelines Research and Evaluation (AGREE II) instrument, which contains six domains for classification. The classification of the CPGs prioritized the domain 3 (developmental rigor) considering: high (score > 60%), moderate (score 30–60%), or low quality (score < 30%). The results were checked for discrepancies and decided by consensus. The interventions were described. Descriptive statistics presented the results.

Results

Of the ten CPGs evaluated, five were of high methodological quality, three were of moderate quality, and two of low quality. Three documents were not recommended for use. The domains with the highest scores were scope and purpose (mean = 90.1%) and clarity of presentation (mean = 88.9%). The domains of editorial independence (mean = 41.4%) and applicability (mean = 29.3%) were those with the lowest score. The most cited interventions in CPGs were the nonpharmacological, such as lifestyle interventions, bladder training, or re-education and pelvic floor muscle training.

Conclusion

Most guidelines showed rigor in development and were recommended for use; however, editorial independence and applicability were domains that need to be improved in these documents. Our findings can guide the choice of CPG for the treatment of urinary incontinence.

Nur mit Berechtigung zugänglich

Abrams P, Andersson KE, Birder L, et al. Fourth international consultation on incontinence recommendations of the international scientific committee: evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Neurourol Urodyn. 2010;29(1):213–40. https://doi.org/10.1002/nau.20870.CrossRefPubMed

Bo K, Frawley HC, Haylen BT, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for the conservative and nonpharmacological management of female pelvic floor dysfunction. Int Urogynecol J. 2017;28(2):191–213. https://doi.org/10.1007/s00192-016-3123-4.CrossRefPubMed

Mendes A, Hoga L, Goncalves B, Silva P, Pereira P. Adult women’s experiences of urinary incontinence: a systematic review of qualitative evidence. JBI database Syst Rev Implement reports. 2017;15(5):1350–408. https://doi.org/10.11124/JBISRIR-2017-003389.CrossRef

Nardi AC, Nardozza Jr. A, Fonseca CEC, Bretas FFH, Truzzi JCCI, Bernardo WM, editores. Diretrizes Urologia – AMB, 1a ed. São Paulo: Sociedade Brasileira de Urologia, Associação Médica Brasileira; 2014.

Lucas MG, Bosch RJL, Burkhard FC, et al. EAU guidelines on surgical treatment of urinary incontinence. Actas Urol Esp. 2013;37(8):459–72. https://doi.org/10.1016/j.acuro.2013.02.002.CrossRefPubMed

Alonso-Coello P, Oxman AD, Moberg J, et al. GRADE evidence to decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines. Gac Sanit. 2018. doi:https://doi.org/10.1016/j.gaceta.2017.03.008.

Alonso-Coello P, Oxman AD, Moberg J, et al. GRADE evidence to decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: clinical practice guidelines. Gac Sanit. 2018;32(2):167.e1–167.e10. https://doi.org/10.1016/j.gaceta.2017.03.008.CrossRef

Gagliardi AR, Brouwers MC. Do guidelines offer implementation advice to target users? A systematic review of guideline applicability. BMJ Open. 2015;5(2):e007047. https://doi.org/10.1136/bmjopen-2014-007047.CrossRefPubMedPubMedCentral

Smiles FB, Mazzei LG, Lopes LC, et al. Critical appraisal of clinical practice guidelines for treatment of urinary incontinence: protocol for a systematic review. Medicine (Baltimore). 2019;98(33):e16698. https://doi.org/10.1097/MD.0000000000016698.CrossRef

10.

de GRC MC, Ribeiro E, Romano-Lieber NS, Stein AT, de Melo DO. Methodological quality and transparency of clinical practice guidelines for the pharmacological treatment of non-communicable diseases using the AGREE II instrument: a systematic review protocol. Syst Rev. 2017;6(1):1–6. https://doi.org/10.1186/s13643-017-0621-5.CrossRef

11.

CNGOF. Diagnosis and management of adult female stress urinary incontinence: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians. Eur J Obstet Gynecol Reprod Biol. 2010. https://doi.org/10.1016/j.ejogrb.2010.02.041.

12.

SOGC. No. 248-guidelines for the evaluation and treatment of recurrent urinary incontinence following pelvic floor surgery. J Obstet Gynaecol Can. 2017. https://doi.org/10.1016/j.jogc.2017.06.009.

13.

Cortesse A, Cardot V, Basset V, Le Normand L, Donon L. Traitement de l’incontinence urinaire associée au prolapsus génital : Recommandations pour la pratique clinique. Prog Urol 2016. doi:https://doi.org/10.1016/s1166-7087(16)30431-6.

14.

Course L. WHO | WHO Guidelines on Integrated Care for Older People (ICOPE). Who. 2018.

15.

SOGC. S. No. 186-conservative management of urinary incontinence. J Obstet Gynaecol Can. 2018. https://doi.org/10.1016/j.jogc.2017.11.027.

16.

de Carvalho IA, Epping-Jordan J, Beard JR. Integrated Care for Older People. 2019. https://doi.org/10.1007/978-3-319-96529-1_19.

17.

Qaseem A, Dallas P, Forciea MA, Starkey M, Denberg TD, Shekelle P. Nonsurgical management of urinary incontinence in women: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2014. https://doi.org/10.7326/M13-2410.

18.

Nambiar AK, Bosch R, Cruz F, et al. EAU guidelines on assessment and nonsurgical Management of Urinary Incontinence. Eur Urol. 2018;73(4):596–609. https://doi.org/10.1016/j.eururo.2017.12.031.CrossRefPubMed

19.

National Institute for Health and Care Excellence. NICE guidance - urinary incontinence and pelvic organ prolapse in women: management. BJU Int. 2019. https://doi.org/10.1111/bju.14763.

20.

Brouwers MC, Kho ME, Browman GP, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. J Clin Epidemiol. 2010. https://doi.org/10.1016/j.jclinepi.2010.07.001.

21.

Kobashi KC, Albo ME, Dmochowski RR, et al. Surgical treatment of female stress urinary incontinence: AUA/SUFU guideline. J Urol. 2017. https://doi.org/10.1016/j.juro.2017.06.061.

22.

Gagliardi AR, Berta W, Kothari A, Boyko J, Urquhart R. Integrated knowledge translation (IKT) in health care: a scoping review. Implement Sci. 2016. https://doi.org/10.1186/s13012-016-0399-1.

23.

Cosgrove L, Bursztajn HJ, Krimsky S, Anaya M, Walker J. Conflicts of interest and disclosure in the American Psychiatric Association’s clinical practice guidelines. Psychother Psychosom. 2009. https://doi.org/10.1159/000214444.

24.

Yang X, Zhang AX, Tan Y, Zhang Z, Zhang J. Critical appraisal of clinical practice guidelines for the diagnosis and treatment of stress urinary incontinence using AGREE II instrument: a systematic review protocol. BMJ Open. 2019. https://doi.org/10.1136/bmjopen-2019-030299.

25.

Bravo-Balado A, Plata M, Trujillo CG, et al. Is the development of clinical practice guidelines for non-neurogenic overactive bladder trustworthy? A critical appraisal using the appraisal of guidelines, research and evaluation (AGREE) II instrument. BJU Int. 2019;123(6):921–2. https://doi.org/10.1111/bju.14684.CrossRefPubMed

26.

Murray AS. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Res Nurs Health. 2019. https://doi.org/10.1002/nur.21946.

27.

Cacciari LP, Dumoulin C, Hay-Smith EJ. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women: a cochrane systematic review abridged republication. Brazilian J Phys Ther. 2019. https://doi.org/10.1016/j.bjpt.2019.01.002.

28.

Aoki Y, Brown HW, Brubaker L, Cornu JN, Daly JO, Cartwright R. Urinary incontinence in women. Nat Rev Dis Prim. 2017. https://doi.org/10.1038/nrdp.2017.42.

29.

Riemsma R, Hagen S, Kirschner-Hermanns R, et al. Can incontinence be cured? A systematic review of cure rates. BMC Med. 2017. https://doi.org/10.1186/s12916-017-0828-2.

30.

Buser N, Ivic S, Kessler TM, Kessels AGH, Bachmann LM. Efficacy and adverse events of antimuscarinics for treating overactive bladder: network meta-analyses. Eur Urol. 2012. https://doi.org/10.1016/j.eururo.2012.08.060.

31.

Ulmsten U, Henriksson L, Johnson P, Varhos G. An ambulatory surgical procedure under local anesthesia for treatment of female urinary incontinence. Int Urogynecol J. 1996. https://doi.org/10.1007/BF01902378.

Titel: Treatment of urinary incontinence: a critical appraisal of clinical practice guidelines with the AGREE II instrument
verfasst von: Flávia Blaseck Sorrilha
Lauren Giustti Mazzei
Luciane Cruz Lopes
Silvio Barberato-Filho
Juliana Castro
Analaura Castro
Claudia Marcela Vélez
Cristiane de Cássia Bergamaschi
Publikationsdatum: 11.03.2021
Verlag: Springer International Publishing
Erschienen in: International Urogynecology Journal / Ausgabe 10/2021
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI: https://doi.org/10.1007/s00192-021-04729-7

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Blutdrucksenkung könnte Uterusmyome verhindern

21.05.2024 Krebsvorsorge in der Gynäkologie Nachrichten

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Treatment of urinary incontinence: a critical appraisal of clinical practice guidelines with the AGREE II instrument